Evidence map›Paper›PMID 37540223›Full record

ArticleBioinformatics (Oxford, England)2023

ProtoCell4P: an explainable prototype-based neural network for patient classification using single-cell RNA-seq.

Guangzhi Xiong, Stefan Bekiranov, Aidong Zhang

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Leveraging AI for cell biology discovery.Biochemical Society transactions · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Guangzhi XiongDepartment of Computer Science, University of Virginia, Charlottesville, VA, United States.ORCID 0000-0002-8049-5298
Stefan BekiranovDepartment of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, United States.
Aidong ZhangDepartment of Computer Science, University of Virginia, Charlottesville, VA, United States.

Funding

IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosisR01AI172112 · NIAID · UNIVERSITY OF VIRGINIA · PI Loren D Erickson, Coleen A McNamara · 2022 to 2026
$6.4M
NIAID NIH HHS R01 AI172112
6 · The paper itself

Abstract

motivationThe rapid advance in single-cell RNA sequencing (scRNA-seq) technology over the past decade has provided a rich resource of gene expression profiles of single cells measured on patients, facilitating the study of many biological questions at the single-cell level. One intriguing research is to study the single cells which play critical roles in the phenotypes of patients, which has the potential to identify those cells and genes driving the disease phenotypes. To this end, deep learning models are expected to well encode the single-cell information and achieve precise prediction of patients' phenotypes using scRNA-seq data. However, we are facing critical challenges in designing deep learning models for classifying patient samples due to (i) the samples collected in the same dataset contain a variable number of cells-some samples might only have hundreds of cells sequenced while others could have thousands of cells, and (ii) the number of samples available is typically small and the expression profile of each cell is noisy and extremely high-dimensional. Moreover, the black-box nature of existing deep learning models makes it difficult for the researchers to interpret the models and extract useful knowledge from them.

resultsWe propose a prototype-based and cell-informed model for patient phenotype classification, termed ProtoCell4P, that can alleviate problems of the sample scarcity and the diverse number of cells by leveraging the cell knowledge with representatives of cells (called prototypes), and precisely classify the patients by adaptively incorporating information from different cells. Moreover, this classification process can be explicitly interpreted by identifying the key cells for decision making and by further summarizing the knowledge of cell types to unravel the biological nature of the classification. Our approach is explainable at the single-cell resolution which can identify the key cells in each patient's classification. The experimental results demonstrate that our proposed method can effectively deal with patient classifications using single-cell data and outperforms the existing approaches. Furthermore, our approach is able to uncover the association between cell types and biological classes of interest from a data-driven perspective. AVAILABILITY AND IMPLEMENTATION: https://github.com/Teddy-XiongGZ/ProtoCell4P.

Indexed as

Single-Cell AnalysisSingle-Cell Gene Expression AnalysisCluster AnalysisGene Expression ProfilingNeural Networks, ComputerSequence Analysis, RNATranscriptome

Identifiers

PMID37540223
PMCPMC10444962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.